Analytical and preanalytical validation of a new mass spectrometric serum 5-hydroxyindoleacetic acid assay as neuroendocrine tumor marker.
Tohmola N, Itkonen O, Sane T, Markkanen H, Joenväärä S, Renkonen R, Hämäläinen E
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of refrigerated and frozen storage, fasting, collection timing, tube type, patient age and gender on levels of 5-HIAA in serum from healthy individuals. The levels and diagnostic specificity of serum 5-HIAA and urinary 5-HIAA and plasma CgA in healthy individuals and patients with neuroendocrine tumors were also investigated. Serum from 9 healthy patients was used to determine the effects of delayed analysis and freeze-thaw cycling. Serum from 18 healthy volunteers was used to determine the effects of collection tube type. Serum from 24 healthy patients was collected before and after breakfast, and diurnal variation was investigated using thawed serum from 7 healthy individuals. Serum 5-HIAA levels were compared with urinary 5-HIAA levels by HPLC and plasma CgA levels by RIA in 112-129 patients with neuroendocrine tumors and 8 healthy individuals. Age and gender effects were investigated using 111 serum specimens from healthy individuals. Unless otherwise specified, all specimens were stored at -20 degrees C until analysis.
Summary of Findings
Levels of serum 5-HIAA were stable for at least 7 days at 4 degrees C, 98 days at -20 degrees C (longest durations examined) and 5 freeze-thaw cycles. Further, comparable 5-HIAA levels were found in specimens stored for 10-12 years at -80 degrees C and those newly obtained and stored at -20 degrees C. Serum 5-HIAA levels were not different between specimens taken after a 12 h fast and after breakfast, or between specimens collected at 8 AM, noon and 4 PM. Levels of 5-HIAA in serum were higher when blood was collected into glass tubes than gel tubes (p=0.0413), and while collection tube type had no other effects on levels of 5-HIAA, the authors recommend against the use of plasma. Patient age and gender had no effect on 5-HIAA levels. Levels of 5-HIAA in serum and urine and levels of CgA in plasma were higher in specimens from patients with neuroendocrine tumors than in healthy individuals (p<0.001), and levels in serum were correlated with those in urine and plasma. There were no significant difference in diagnostic specificity for neuroendocrine tumors between serum (97%), plasma (86%) and urine (100%) specimens.
Biospecimens
FluidPlasmaFluidUrineFluidSerumFluidBloodPreservation Types
FrozenDiagnoses
NormalNeoplasticCarcinomaPlatforms
Small moleculeHPLCSmall moleculeLC-MS or LC-MS/MSProteinRadioimmunoassayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Patient age 18-30 years31-50 years51-70 years>70 yearsPreaquisition Patient gender FemaleMaleBiospecimen Acquisition Biospecimen location PlasmaSerumUrineBiospecimen Acquisition Time of biospecimen collection 4 PM8 AMAfter 12 h fastAfter breakfastNoonBiospecimen Acquisition Type of collection container/solution Glass tubeLithium-heparin tubesSerum catalyzator tubesSerum gel tubesBiospecimen Aliquots and Components Blood and blood products PlasmaSerumStorage Freeze/thaw cycling 1 cycle2 cycles3 cycles4 cycles5 cyclesStorage Storage duration 0 days1 day10-12 years14 days2 days21 days3 days35 days4 days5 days56 days6 days7 days98 daysStorage Storage temperature -20 degrees C4 degrees C